Related Experiment Video
Updated: Jul 3, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes
C Zavaleta1, A de la Zerda, Z Liu
1Molecular Imaging Program at Stanford, Department of Radiology, Stanford University, 1201 Welch Road, Stanford, California 94305-5484, USA.
Abstract:
An optimized noninvasive Raman microscope was used to evaluate tumor targeting and localization of single walled carbon nanotubes (SWNTs) in mice. Raman images were acquired in two groups of tumor-bearing mice. The control group received plain-SWNTs, whereas the experimental group received tumor targeting RGD-SWNTs intravenously. Raman imaging commenced over the next 72 h and revealed increased accumulation of RGD-SWNTs in tumor ( p < 0.05) as opposed to plain-SWNTs. These results support the development of a new preclinical Raman imager.
Insights
Targeted single-walled carbon nanotubes (SWNTs) showed enhanced accumulation in tumors compared to plain SWNTs in mice. This study supports the development of advanced preclinical Raman imaging for tumor localization.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Optical Imaging
Background:
- Single-walled carbon nanotubes (SWNTs) are promising nanomaterials for biomedical applications.
- Targeted delivery of SWNTs to tumors can improve therapeutic efficacy and reduce off-target effects.
- Noninvasive imaging techniques are crucial for monitoring the biodistribution of nanomaterials in vivo.
Purpose of the Study:
- To evaluate the tumor targeting and localization of SWNTs in a preclinical mouse model using noninvasive Raman microscopy.
- To compare the accumulation of RGD-conjugated SWNTs (RGD-SWNTs) with plain SWNTs in tumor tissues.
Main Methods:
- An optimized noninvasive Raman microscope was employed for imaging.
- Two groups of tumor-bearing mice were used: one received plain-SWNTs, and the other received RGD-SWNTs intravenously.
- Raman imaging was performed over 72 hours to track SWNT accumulation.
Main Results:
- Raman imaging revealed significantly increased accumulation of RGD-SWNTs in tumor tissues compared to plain-SWNTs (p < 0.05).
- The study demonstrated successful in vivo tracking and localization of SWNTs within tumors.
Conclusions:
- Targeted RGD-SWNTs exhibit enhanced tumor accumulation, validating their potential for tumor-specific delivery.
- The findings support the development of a novel preclinical Raman imager for evaluating nanocarrier biodistribution and tumor targeting.
More Related Videos
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019